Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001315863-14-000510
Filing Date
2014-08-14
Accepted
2014-08-14 16:50:48
Documents
1
Period of Report
2014-08-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 4916
  Complete submission text file 0001315863-14-000510.txt   7060
Mailing Address 1924 SOUTH IRICA SUITE 1120 TULSA OK 741046529
Business Address
FROHLICH PHIL (Reporting) CIK: 0001127429 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 141043843

Mailing Address 1924 SOUTH UTICA SUITE 1120 TULSA OK 74104-6429
Business Address 1924 SOUTH UTICA SUITE 1120 TULSA OK 74104-6429 918-747-3412
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (Reporting) CIK: 0001166152 (see all company filings)

State of Incorp.: OK | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 141043844

Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations